Health News

Texting, Driving Teens Take More Risks
The dangers of texting and driving have been well established, especially for less experienced drivers. But teens who admit to texting while driving may be taking other risks as well.
More Lead Means Lagging Reading Scores
Lead is a well-known environmental risk for children. Too much exposure to lead can have long-term effects on a child's brain. And it may not take much lead to have an effect.
When Teen Mom Welcomes Baby #2
The number of teenagers having a second baby has dropped since 2007. However, about one in five girls in the US is still having a repeat birth in her adolescence.
Needing a Little Help from Their Friends
Even if adults over age 65 are living on their own, they still may be experiencing memory problems or confusion. Many of these adults may also need help for daily activities.
Celiac's Focus on the Family
While families can pass down a lot of things from one generation to the next, one thing that unfortunately gets caught in the mix is celiac disease.
Faces of Arthritis in May
There's osteoarthritis. And rheumatoid arthritis. And infectious arthritis, childhood arthritis, Still's disease, lupus, Sjogren's disease and many more. In total, there are more than 100 kinds of arthritis.
Wheeze Relief
Pre-term babies are at risk of developing a variety of complications and health issues as they grow. One common issue for these children is wheezing.
Vitamins for Old Eyes, But Not Omega-3s
As people age, their eyesight can worsen. Millions get a condition that can lead to blindness. A vitamin regimen can help, but adding supplements provides no extra benefit.
Diabetes Rx and Breast Cancer Survival
The diabetes drug metformin has been something of a darling in the cancer world of late. Previous research has shown that it may help prevent or beat cancer. But a new study has come along that creates a question mark.
Novartis Rx Ilaris Approved by FDA
Novartis announced today that the US Food and Drug Administration (FDA) has approved Ilaris ® (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients aged 2 years and older.